Theoretically Informed Behavioral Intervention

Starting soon · Not applicable

Conditions studied: HIV, CVD, Metabolic Disease

In brief

The goal of this waitlist control clinical trial is to learn if the tailored LEARN 2 platform can prevent HIV-related comorbidities with shared risk factors in men ages 18 and older living with HIV. The main question\[s\] are: 1. Can the virtual environment improve quality of life among these participants? 2. Does the LEARN 2 platform effectively serve as prevention education for HIV comorbidity shared risk factors? Researchers will compare participants receiving the LEARN2 virtual environment intervention to those in a waitlist control group to see if the intervention leads to improvements in quality of life and reductions in risk factors. Participants will be asked to: 1. Engage with the virtual environment weekly. 2. Participate in virtual live health educator sessions. 3. Complete daily assessments of personal health behaviors through Ecological Momentary Assessment.

Key facts

Study ID

NCT06580184

Run by

Yale University

People needed

164

Starts

2026-10-01

Expected to finish

2029-03-31

Last updated by the study team

2026-06-16

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Self-identify as:
• living with HIV
• English speaking
• Access to a device compatible with LEARN 2

You may not qualify if…

• medical history of serious complications such as heart attack, stroke, cognitive impairment, or cancer.

Where it is running

• Yale University — Orange, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.